Bertelsmann-backed paywall management software provider Zephr is set to be acquired by Zuora in a $44m deal while Meituan co-led a $875m round for EV battery producer Sunwoda.

Public markets

Third Harmonic Bio, the US-based allergy and inflammatory therapy developer backed by pharmaceutical firm Novartis, has filed to list on the Nasdaq Global Market. The company had closed a $105m series B round in December 2021 and still had $113m cash on hand as of June this year, according to the securities filing. Novartis owns a 9.4% stake having licensed several patents to Third Harmonic.

M&A

Subscription management tool provider Zuora has agreed to acquire…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn